However, in vitro sensitivity to FKBP12 and the clinical characteristics of a patient with FOP are inconsistent18,34, suggesting that another factor might prevent the dimerization of ALK2 ICDs under inactive conditions. The gene discussed is FKBP1A; the disease is fibrodysplasia ossificans progressiva.